Related Experiment Video
Updated: Feb 5, 2026

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
Published on: March 8, 2012
Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated
Arnoo Shaiykova1, Armelle Pasquet2, Cécile Goujard1,3
1Inserm, CESP, U1018, Paris-Sud University, Le Kremlin-Bicêtre.
Insights
Reduced bone mineral density (BMD) is common in young men with HIV despite viral control. Lower BMI, decreased estradiol, and lower lean mass are associated with reduced BMD, while longer combination antiretroviral therapy (cART) duration shows a protective effect.
Area of Science:
- Endocrinology
- Infectious Diseases
- Bone Metabolism
Background:
- Reduced bone mineral density (BMD) is a significant comorbidity in people living with HIV (PLHIV).
- Understanding BMD status in virologically controlled PLHIV is crucial for managing long-term health.
- Younger PLHIV men on combination antiretroviral therapy (cART) represent a population where BMD changes may not be fully characterized.
Purpose of the Study:
- To determine the prevalence of reduced BMD in young, virologically controlled men with HIV.
- To identify factors associated with reduced BMD in this population.
- To evaluate the impact of cART duration on BMD.
Main Methods:
- A bicentric cross-sectional study involving men under 50 years old with HIV-RNA <50 copies/ml on cART.
- BMD measurements of the lumbar spine and hip using dual-energy X-ray absorptiometry (DXA).
- Statistical analyses including linear and polytomous logistic regression to identify associated factors.
Main Results:
- Nearly half (48.3%) of the 230 participants had reduced BMD (osteopenia or osteoporosis).
- Lower Body Mass Index (BMI), decreased estradiol levels, and lower lean mass were significantly associated with reduced BMD.
- Longer duration of cART, especially over 3 years, demonstrated a protective effect on BMD.
Conclusions:
- A high prevalence of reduced BMD exists in young men with HIV, even with effective viral suppression.
- Factors such as BMI, estradiol, and lean mass play a role in BMD reduction.
- Current recommendations for BMD screening may need to be extended to PLHIV under 50 with stable viral control for over three years on cART.
Objective:
Reduced bone mineral density (BMD) is a frequent comorbidity observed in people living with HIV (PLHIV). We aimed to determine the prevalence of reduced BMD and its associated factors among young PLHIV men, virologically controlled by combination antiretroviral therapy (cART).
Design:
A bicentric cross-sectional study.
Methods:
We selected men, aged less than 50 years, treated by cART, with HIV-RNA less than 50 copies/ml. BMDs of lumbar spine and hip were measured by dual-energy X-ray absorptiometry (DXA). A Z-score at either site between -1.0 and -2.0 or -2 or less defined osteopenia or osteoporosis, respectively. Linear and polytomous logistic regression analyses were performed.
Results:
Among 230 men with a median age of 43 [interquartile range (IQR), 36-47] years, BMI of 23.5 (21.3-25.3) kg/m(2) and median duration of cART of 4.2 (1.7-8.5) years, reduced BMD was diagnosed in 48.3%. In multivariate analyses, BMI decrease was associated with a risk of osteopenia [odds ratio (OR) = 1.17, P < 0.01] and osteoporosis (OR = 1.24, P < 0.01). Oestradiol levels decrease were associated with osteoporosis (OR = 1.32, P < 0.05) and lower lean mass with osteopenia (OR = 2.98, P < 0.01). There was a protective effect of the duration of cART (OR = 0.87, P < 0.01), which was even greater when the duration was more than 3 years (OR = 0.44, P = 0.02).
Conclusion:
There is a high prevalence of reduced BMD among young men, despite persistent virological control of HIV-infection. This observation raises the question of extending current recommendations for BMD assessment to PLHIV aged < 50 years for whom BMD has stabilized after cART initiation, i.e. treated for more than three years.
More Related Videos
Related Concept Videos
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Water and Mineral Acquisition
Minerals
Major...
Transcription Factors

